elbasvir

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2015-2017
0102020152017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
BACKGROUND & AIMS Patients infected with hepatitis C virus (HCV) genotype 1, 4, or 6, with or without cirrhosis, previously… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
2017
2017
BACKGROUND & AIMS Elbasvir (an NS5A inhibitor) and grazoprevir (an NS3/4A protease inhibitor) are direct-acting antiviral agents… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2016
2016
BACKGROUND The phase 2 C-SALVAGE study (Hepatitis C-Salvage Study for Patients who Failed DAA/PR Therapy) demonstrated a 96.2… (More)
  • table 1
Is this relevant?
2016
2016
The selection of resistance-associated variants (RAVs) against single agents administered to patients chronically infected with… (More)
Is this relevant?
Highly Cited
2015
Highly Cited
2015
BACKGROUND Chronic hepatitis C virus (HCV) infection in patients with stage 4-5 chronic kidney disease increases the risk of… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2015
Highly Cited
2015
BACKGROUND There is a high medical need for an interferon-free, all-oral, short-duration therapy for hepatitis C virus (HCV) that… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Is this relevant?
Highly Cited
2015
Highly Cited
2015
BACKGROUND Both hepatitis C virus (HCV) mono-infected and HIV/HCV co-infected patients are in need of safe, effective, all-oral… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2015
Highly Cited
2015
BACKGROUND Hepatitis C virus (HCV) infection is a leading cause of morbidity and mortality in patients with HIV-1. The C-EDGE CO… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
2015
2015
BACKGROUND & AIMS The Phase-2 C-SALVAGE study evaluated an investigational interferon-free combination of grazoprevir (a NS3/4A… (More)
  • figure 1
  • table 1
  • table 2
  • table 2
  • table 3
Is this relevant?
2015
2015
Elbasvir is an investigational NS5A inhibitor with in vitro activity against multiple HCV genotypes. Antiviral activity of… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?